受强制性开放获取政策约束的文章 - Patrick A. Baeuerle了解详情
无法在其他位置公开访问的文章：3 篇
T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct
M Aigner, J Feulner, S Schaffer, R Kischel, P Kufer, K Schneider, A Henn, ...
Leukemia 27 (5), 1107-1115, 2013
强制性开放获取政策： German Research Foundation
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection
J Pendzialek, K Roose, A Smet, B Schepens, P Kufer, T Raum, ...
Antiviral research 141, 155-164, 2017
强制性开放获取政策： Research Foundation (Flanders)
Myocardial gene expression of matched hibernating and control tissue from patients with ischemic left ventricular dysfunction
D Zohlnhöfer, TG Nührenberg, F Haas, F Bengel, A Schömig, ...
Heart and Vessels 23, 230-242, 2008
强制性开放获取政策： German Research Foundation
可在其他位置公开访问的文章：8 篇
Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
O Gires, M Pan, H Schinke, M Canis, PA Baeuerle
Cancer and Metastasis Reviews 39 (3), 969-987, 2020
强制性开放获取政策： German Research Foundation
CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell–engaging antibody AMG 330
C Krupka, P Kufer, R Kischel, G Zugmaier, J Bögeholz, T Köhnke, ...
Blood, The Journal of the American Society of Hematology 123 (3), 356-365, 2014
强制性开放获取政策： German Research Foundation
EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells
M Cioffi, J Dorado, PA Baeuerle, C Heeschen
Clinical Cancer Research 18 (2), 465-474, 2012
强制性开放获取政策： Government of Spain
Redirected lysis of human melanoma cells by a MCSP/CD3-bispecific BiTE antibody that engages patient-derived T cells
H Torisu-Itakura, HF Schoellhammer, MS Sim, RF Irie, S Hausmann, ...
Journal of immunotherapy 34 (8), 597-605, 2011
强制性开放获取政策： US National Institutes of Health
Antiviral activity of HIV gp120-targeting bispecific T cell engager antibody constructs
J Brozy, E Schlaepfer, CKS Mueller, MA Rochat, SK Rampini, R Myburgh, ...
Journal of virology 92 (14), 10.1128/jvi. 00491-18, 2018
强制性开放获取政策： Swiss National Science Foundation
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
NK Mehta, M Pfluegler, K Meetze, B Li, I Sindel, F Vogt, M Marklin, ...
Journal for immunotherapy of cancer 10 (3), 2022
强制性开放获取政策： Helmholtz Association
Functional enhancement of mesothelin-targeted TRuC-T cells by a PD1-CD28 chimeric switch receptor
D McCarthy, M Lofgren, A Watt, H Horton, P Kieffer-Kwon, J Ding, ...
Cancer Immunology, Immunotherapy 72 (12), 4195-4207, 2023
强制性开放获取政策： German Research Foundation, European Commission, Federal Ministry of …
Generating a novel bispecific nanobody to enhance antitumor activity
Q Ge, T Sun, Y Bian, X Xiao, J Zhu
Pharmaceutical Fronts 2 (02), e100-e108, 2020
强制性开放获取政策： 国家自然科学基金委员会
出版信息和资助信息由计算机程序自动确定